Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Change in Acquisitions & Divestments (2019 - 2025)

Crinetics Pharmaceuticals has reported Change in Acquisitions & Divestments over the past 7 years, most recently at $271.2 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $271.2 million for Q4 2025, up 47.42% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (up 105.64% YoY), and the annual figure for FY2025 was $1.2 billion, up 105.64%.
  • Change in Acquisitions & Divestments for Q4 2025 was $271.2 million at Crinetics Pharmaceuticals, down from $382.4 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for CRNX hit a ceiling of $382.4 million in Q3 2025 and a floor of $244000.0 in Q4 2021.
  • Median Change in Acquisitions & Divestments over the past 5 years was $87.3 million (2023), compared with a mean of $116.2 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: crashed 98.12% in 2021 and later soared 28870.49% in 2022.
  • Crinetics Pharmaceuticals' Change in Acquisitions & Divestments stood at $244000.0 in 2021, then soared by 28870.49% to $70.7 million in 2022, then rose by 22.62% to $86.7 million in 2023, then skyrocketed by 112.24% to $184.0 million in 2024, then skyrocketed by 47.42% to $271.2 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $271.2 million (Q4 2025), $382.4 million (Q3 2025), and $224.0 million (Q2 2025) per Business Quant data.